Neurorehabilitation Devices Market By Product (Neurorobotic Systems, Brain Computer Interface), Application (Stroke, Parkinson’s Disease, Brain & Spinal Cord Injury), End-User (Rehabilitation Centers, Hospitals & Clinics), & Region for 2024-2031

Neurorehabilitation Devices Market Valuation – 2024-2031

In the neurorehabilitation devices market, the increased prevalence of neurological illnesses, such as stroke, Parkinson’s disease, and spinal cord injuries, is a major driver. As the world population ages, the prevalence of these illnesses rises, resulting in a significant demand for effective rehabilitation options. Technological improvements have resulted in the development of novel neurorehabilitation devices that improve patient outcomes and increase independence. These factors all contribute to the growing need for neurorehabilitation devices. The market size surpass USD 2466.43 Million valued in 2024 to reach a valuation of around USD 6373.74 Million by 2031.

The growing emphasis on early intervention and patient-centered care is driving market expansion. Neurorehabilitation devices serve an important role in improving the quality of life for people with neurological impairments by allowing for speedier recovery and increased functional capacities. Supportive government measures and rising healthcare expenditures are creating a favorable environment for the market’s growth. These combined factors are generating significant growth in the neurorehabilitation device market. The rising demand for cost-effective and efficient neurorehabilitation devices is enabling the market grow at a CAGR of 13.90% from 2024 to 2031.

Neurorehabilitation Devices MarketDefinition/ Overview

Neurorehabilitation devices are specialized instruments that help people with neurological abnormalities regain or improve their motor, sensory, and cognitive abilities. These devices use a variety of technologies to aid in the rehabilitation process, including robotics, virtual reality, and brain-computer interfaces. They treat disorders such as stroke, traumatic brain injury, and neurodegenerative diseases using structured and customized therapy that aims to improve neuronal plasticity and functional recovery.

Neurorehabilitation devices are utilized in clinical settings to provide individualized rehabilitation regimens that improve patient results. For instance, robotic exoskeletons aid stroke sufferers in regaining motor function by guiding limb movements, whilst virtual reality systems provide interesting environments for cognitive and motor practice.

These devices show promise, with continual advances in artificial intelligence and machine learning improving their ability to adapt to unique patient demands. Real-time neurofeedback and more advanced brain-computer interfaces are projected to customize and improve therapy, thereby increasing recovery rates and quality of life for those with neurological disabilities.

What are the Factors that Surge the Demand for the Neurorehabilitation Devices Market?

The neurorehabilitation devices market are expected to propel the technological developments over the forecast period. Robotics, virtual reality, and brain-computer interface advances are boosting these devices’ capabilities, making them more useful in neurological recovery. The has made a significant investment in neuroscience research, allocating nearly USD 2.27 Billion for fiscal year 2020, demonstrating its commitment to creating novel neurorehabilitation technology. This investment is likely to speed the development and implementation of improved rehabilitation techniques, hence boosting market growth.

The increase in healthcare expenditure is likely to boost the growth of the neurorehabilitation devices market. The significant increase in healthcare spending, as seen by a 9.7% increase to USD 4.1 Trillion in US national health spending in 2020, demonstrates an increasing commitment to investing in modern medical technology. This global growing trend in healthcare expenditure supports the broader adoption of cutting-edge neurorehabilitation devices by increasing access to these technologies and promoting market expansion.

How Does the Patient Compliance Hinder the Growth of the Neurorehabilitation Devices Market?

Patient compliance has a substantial impact on the growth of the neurorehabilitation device market because it influences the effectiveness and adoption of these technologies. High levels of patient compliance with prescribed rehabilitation regimens result in better outcomes, driving demand for neurorehabilitation devices. When patients are engaged and follow their therapy plans, rehabilitation program success rates improve, indicating the utility of these devices and driving further investment and development. Low compliance, on the other hand, can reduce a device’s perceived effectiveness, thus slowing market growth. As a result, improving patient involvement and compliance is critical for maintaining and developing the neurorehabilitation devices market.

The high cost of neurorehabilitation devices has an impact on market growth by limiting access and affordability. Expensive technologies may limit their use to well-funded healthcare facilities or rich patients, restricting widespread adoption and slowing market growth. Although technological developments may promote innovation and enhance outcomes, the financial barrier continues to be a significant problem. Addressing cost challenges through manufacturing breakthroughs, increased competition, and cost-effective solutions is essential to making these devices more accessible and driving market growth.

Category-Wise Acumens

Will the Demand for Robotic Arms Propel the Neurorobotic Systems Segment?

Neurorobotic systems are now dominating the neurorehabilitation device market. Robotic arms are expected to create substantial expansion in the neurorobotic systems section of the neurorehabilitation device market. These modern robotic technologies improve the precision and effectiveness of rehabilitation by offering consistent and controlled support during therapy. Robotic arms improve patient outcomes by allowing for repetitive, task-specific exercises that promote neuronal plasticity, driving demand for neurorobotic systems. Their increasing integration into rehabilitation programs highlights their potential to transform neurorehabilitation, hence driving market growth in this category.

Exoskeletons are expected to fuel expansion in the neurorobotic systems section of the neurorehabilitation devices market. These exoskeletons provide total support and assistive mobility, improving the rehabilitation process by allowing patients with severe motor impairments to participate in meaningful physical activities. Their capacity to aid functional recovery through repetitive, regulated movements while also providing support during therapy makes them extremely effective in neurorehabilitation. The use of encompassing exoskeletons is expected to greatly boost the neurorobotic systems market, highlighting their expanding importance in advanced rehabilitation procedures.

The capacity to assess and quantify patient performance using these technologies has resulted in better treatment outcomes, making them the favored option for many rehabilitation centers.

Will the Trained Professionals Fuel the Hospitals & Clinics Segment for the Neurorehabilitation Devices Market?

The hospitals & clinics segment currently dominates the neurorehabilitation devices market. The presence of trained professionals will fuel expansion in the neurorehabilitation devices market’s hospital and clinic segments. Skilled healthcare personnel are required to successfully adopt and optimize the use of modern neurorehabilitation technologies. Their knowledge ensures that patients receive proper, individualized therapy, allowing these devices to provide the most benefit possible. As hospitals and clinics continue to spend on training and hiring experienced personnel, they improve the quality and effectiveness of neurorehabilitation services, attracting more patients and increasing demand for these devices in the healthcare sector.

The neurorehabilitation devices market will propel the hospital and clinic segment combination of advanced facilities and trained experts. Advanced facilities equipped with cutting-edge neurorehabilitation devices, as well as qualified experts capable of utilizing this technology, ensure high-quality, tailored patient treatment. This collaboration improves the effectiveness of rehabilitation programs, bringing more patients to hospitals and clinics for treatment. As a result, demand for neurorehabilitation devices rises in these settings, driving market expansion in this sector.

Gain Access into Neurorehabilitation Devices Market Report Methodology

Country/Region-wise Acumens

Will the Advanced Research and Development Boost the North American Region for the Neurorehabilitation Devices Market?

North America, holds a dominant position in the neurorehabilitation devices market. Advanced research and development are propelling the neurorehabilitation devices market in North America. The United States, in particular, is driving this effort with significant investments in neurological research and rehabilitation technologies. The National Institutes of Health (NIH) will spend around USD 9.7 Billion on brain research in fiscal year 2023, with a large chunk of that going toward neurorehabilitation. The got USD 2.8 Billion, up 3.5% from the previous year. The high frequency of neurological illnesses, such as 17% of children diagnosed with developmental impairments and 6.7 million Americans aged 65 and older living with Alzheimer’s dementia, adds to this demand.

The well-established healthcare infrastructure will propel the neurorehabilitation devices market in North America. The United States and Canada, with their modern medical facilities and high adoption rates of cutting-edge technology, provide an ideal setting for market expansion. According to the American Hospital Association (AHA), there will be 6,093 hospitals in the United States in 2023, many of which will have cutting-edge rehabilitation departments.The Centers for Medicare & Medicaid Services (CMS) estimated 1,166 inpatient rehabilitation centers in 2021, with specialized intensive care. The high prevalence of neurological illnesses, with the CDC estimating 795,000 strokes each year in the United States and the National Spinal Cord Injury Statistical Center reporting 17,900 new spinal cord injury cases each year, emphasizes the need for sophisticated neurorehabilitation technologies.

These factors emphasize a sizable patient population that could benefit from such devices, which is boosting demand for effective and novel neurorehabilitation solutions in North America.

Will the Urbanization and Increasing Disposable Incomes Expand the Asian Pacific Region for the Neurorehabilitation Devices Market?

The Asia-Pacific region is experiencing the most rapid growth in the neurorehabilitation devices market. Urbanization and increasing disposable incomes will fuel Asia Pacific’s neurorehabilitation device market. Countries such as China, India, and Japan are undergoing fast urbanization and economic development, resulting in increased access to healthcare services and innovative medical technologies. According to UNESCAP, the region’s urban population is expected to increase from 2.3 billion in 2019 to 3.5 billion by 2050, while the World Bank reports that GDP per capita in East Asia and the Pacific increased from $10,291 in 2010 to $14,480 in 2021, indicating a significant increase in purchasing power.

The prevalence of neurological disorders underscores this requirement, with the World Health Organization estimating that neurological disorders account for 6.8% of the overall disease burden in the Western Pacific and 8.7% in Southeast Asia. Furthermore, a 2023 study in The Lancet Neurology predicts that the number of persons with dementia in Asia Pacific will rise from 20.1 million in 2020 to 61.4 million by 2050. These considerations highlight the growing patient population in the Asia Pacific who could benefit from neurorehabilitation equipment, which is being driven by urbanization, increased incomes, and an increase in the prevalence of neurological illnesses.

Expanding healthcare awareness will drive the Asia Pacific neurorehabilitation devices market. In North America, rising public health education and patient empowerment in nations such as China, India, and Japan are leading to a greater understanding of neurological diseases and the benefits of rehabilitation therapies. As awareness rises, the region’s large population of people suffering from neurological illnesses learns more about the importance of neurorehabilitation. This increased awareness, combined with a focus on improving long-term care and quality of life, is generating strong demand for neurorehabilitation equipment in the Asia Pacific region.

Competitive Landscape

The neurorehabilitation devices market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the neurorehabilitation devices market include

• Bionik Labs
• Ectron Ltd.
• REHABTRONICS INC.
• DIH International Limited (Hocoma AG)
• Abbott Laboratories (St. Jude Medical Inc.)
• MagVenture A/S
• Helius Medical Technologies
• Ekso Bionics
• Rehab-Robotics Company Limited
• Neurodan
• Rex Bionics
• Ottobock SE & Co. KGaA
• NeuroMetrix, Inc.

Latest Developments

• In February 2023, MindMaze debuted Iza, a US Food and Drug Administration (FDA)–listed and CE-marked smart peripheral device for patients with weak hand motor abilities. Izar is intended to address a major vacuum in neurological care by providing the most effective treatment for manual dexterity and strength in a variety of neurological diseases.
• In September 2022, Sumitomo Pharma Co. Ltd. and MELTIN MMI agreed to launch and commercialize the MELTz® Hand Rehabilitation System. The product was co-developed by the aforementioned companies, but MELTIN acquired device certification as a distributor and manufacturer.
• In April 2022, Blackrock Neurotech purchased MindX to accelerate the development of highly superior brain-computer interface technologies. By merging its hardware DNA with MindX’s software DNA, Blackrock hoped to increase neural data analysis while also providing flexibility and adaptation for a wide range of BCI applications.

Report Scope

Neurorehabilitation Devices Market, By Category

Product

• Neurorobotic Systems
• Brain Computer Interface
• Wearable Devices
• Brain Stimulators

Application

• Stroke
• Parkinson’s Disease
• Brain & Spinal Cord Injury
• Cerebral Palsy
• Multiple Sclerosis

End-User

• Rehabilitation Centers
• Hospitals & Clinics
• Home Care

Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.